Benzinga's Top Downgrades - Biomarin Pharmaceutical (NASDAQ:BMRN), Applied Industrial Techs (NYSE:AIT)

Analysts at Credit Suisse downgraded

Lumenis LtdLMNS

from Outperform to Underperform. The price target for Lumenis is set to $14. Lumenis' shares closed at $13.62 yesterday. Analysts at Longbow Research downgraded

Applied Industrial TechnologiesAIT

from Neutral to Underperform. Applied Industrial shares closed at $43.20 yesterday. Analysts at Raymond James downgraded

Finisar CorporationFNSR

from Strong Buy to Outperform. Finisar shares closed at $22.15 yesterday. Analysts at Piper Jaffray downgraded

Zoe's Kitchen IncZOES

from Overweight to Neutral. Zoe's Kitchen shares closed at $42.09 yesterday. Cantor Fitzgerald downgraded

Public StoragePSA

from Buy to Hold. Public Storage shares closed at $192.46 yesterday. Baird downgraded

BioMarin Pharmaceutical Inc.BMRN

from Outperform to Neutral. BioMarin Pharmaceutical shares closed at $138.66 yesterday. RBC Capital downgraded

BP plc (ADR)BP

from Outperform to Sector Perform. BP shares closed at $41.28 yesterday. Macquarie downgraded

Corrections Corp Of AmericaCXW

from Outperform to Neutral. Corrections' shares closed at $34.80 yesterday.

Market News and Data brought to you by Benzinga APIs